Study of extended-spectrum β-lactamase-producing bacteria from urinary tract infections in Bangladesh

Tzu Chi Medical Journal

Volumn 25, Issue 1, 2013, Pages 39-42

  Khan, Shahidul Ahmed ^a   Feroz, Farahnaaz ^a   Noor, Rashed ^a  

^a STAMFORD UNIVERSITY BANGLADESH   (Bangladesh)

Author keywords

Antimicrobial susceptibility; Extended spectrum lactamase; Urinary tract infection

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFRADINE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MECILLINAM; NALIDIXIC ACID; NETILMICIN; NITROFURANTOIN;

ACINETOBACTER; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; DISK DIFFUSION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GAMMAPROTEOBACTERIA; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PSEUDOMONAS; SCHOOL CHILD; STAPHYLOCOCCUS; URINARY TRACT INFECTION;

EID: 84875077110     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcmj.2013.01.008     Document Type: Article

References (32)

1. Gonzalez C.M., Schaeffer A.J. Treatment of urinary tract infection: what's old, what's new, and what works. World J Urol 1999, 17:372-382.
2. Akram M., Shaid M., Khan A.U. Etiology and antibiotic resistance patterns of community acquired urinary tract infection in JNNC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007, 6:4.
3. Griebling T.L. Urinary tract infection in women. Urologic diseases in America 2001, 587. US Government Printing Office, Washington, DC. M.S. Litwin, C.S. Saigal (Eds.).
4. Goering R.V., Dockrell H.M., Zuckerman M., Wakelin D., Roitt I.M., Mims C., et al. Mims' Medical Microbiology 2008, Mosby, Philadelphia. 4th ed.
5. Travis L.B., Bruhard B.H. Infections of the urinary tract. Rudolph's pediatrics 1996, 1388-1392. Appleton & Lange, Connecticut. 20th ed. A.M. Rudolph (Ed.).
6. Tolkoff N.E., Rubin R.H. Urinary tract infection: significance and management. Bull NY Acad Med 1986, 62:131-148.
7. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003, 49:71-82.
8. Mathai D., Lewis M.T., Kugler K.C., Pfaller M.A., Jones R.N. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the Sentry Antimicrobial Surveillance Program (North America, 1998). Diag Microbiol Infect Dis 2001, 39:105-116.
9. Gniadkowski M. Evolution and epidemiology of extended spectrum β-lactamases (ESBL) and ESBL producing microorganisms. Clin Microbiol Infect 2001, 7:597-608.
10. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
11. Okeke I.N., Fayinka S.T., LamiKanra A. Antibiotic resistance in Escherichia coli from Nigerian students, 1986-1998. Emerg Infect Dis 2000, 6:393-396.
12. Baron E.J., Peterson L.R., Finegold S.M. Bailey and Scott's diagnostic microbiology 1994, Mosby, Philadelphia. 9th ed.
13. Cappuccino J.G., Sherman N. Microbiology- A laboratory manual 1996, Benjamin Cummings, California. 4th ed.
14. Bauer A.W., Kirby W.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized simple disc method. Am J Clin Pathol 1966, 45:493-496.
15. Munshi S.K., Rahman M.M., Noor R. Detection of virulence potential of diarrheagenic Escherichia coli isolated from surface water of rivers surrounding Dhaka City. J Bang Acad Sci 2012, 36:109-121.
16. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 2011, The Institute, Wayne (PA).
17. Kumar M.S., Lakshmi V., Rajagopalan R. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Ind J Med Microb 2006, 24:208-211.
18. Tallis E., Rudensky B., Attias D., Raveh D., Schlesinger Y., Yinnin A.M. In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus. Diagn Microbiol Infect Dis 1999, 35:121-126.
19. Ahmed A.A., Osman H., Mansour A.M., Musa H.A., Ahmed A.B., Karrar A., et al. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am J Trop Med Hyg 2000, 63:259-263.
20. Gul N., Mujahid T.Y., Ahmad S. Isolation, identification and antibiotic resistance profile of indigenous bacterial isolates from urinary tract infection patients. Pak J Biol Sci 2004, 7:2051-2054.
21. Gales A.C., Jones R.N., Andrade S.S., Sader H.S. Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 2005, 100:571-577.
22. Kahlmeter G., Menday P., Cars O. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 2003, 53:1005-1010.
23. Khleifat K.M., Abboud M.M., Omar S.S., Al-Kurishy J.H. Urinary tract infection in South Jordanian population. J Med Sci 2006, 6:5-11.
24. Mahbub M.M., Azmuda N., Maumood B., Khan S.I., Birkeland N.K., Akhter H. Drug resistance and curli fimbrination of Escherichia coli isolated from Bangladeshi patients with urinary tract infections. Dhaka Univ Biol Sco 2011, 20:123-130.
25. Lina T.T., Rahman S.R., Gomes D.J. Multiple-antibiotic resistance mediated by plasmids and integrons in uropathogenic Escherichia coli and Klebsiella pneumoniae. Bangladesh J Microbial 2007, 24:19-23.
26. Oluremi B.B., Idowu A.O., Olaniyi J.F. Antibiotic susceptibility of common bacterial pathogens in urinary tract infections in a teaching hospital in Southwestern Nigeria. Afr J Microbiol Res 2011, 5:3658-3663.
27. Jilani M.S.A., Murshed M., Sultana L., Hasan Z. Common clinically important aerobic bacteria and their antibiotic resistance pattern of Dhaka city and its vicinity. Bangladesh Med Coll J 2008, 14:66-71.
28. Health Protection Agency. Management of infection guidance for primary C for consultation and local adaptation. Available at: 2012. [accessed 13.09.12]. http://www.hpa.org.uk/servlet/Satellite.
29. Bean D.C., Krahe D., Wareham D.W. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008, 7:13.
30. Alós J.I., Serrano M.G., Gómez-Garces J.L., Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 2005, 11:199-203.
31. Kothari A., Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries 2008, 2:354-358.
32. Olukemi O.A., Adeola F. Extended-spectrum beta-lactamase production among clinical isolates of Escherichia coli. Int Res J Microbiol 2012, 3:140-143.